Skip to main content
OpenTrials

Clinical trial condition

Myosarcoma

Explore clinical trials studying Myosarcoma. Study availability and eligibility vary by location and protocol.

198 public trials 39 recruiting studies
Refine in advanced search Browse all conditions

Myosarcoma trial results

Recruiting

Silmitasertib (CX-4945) in Combination With Chemotherapy for Relapsed Refractory Solid Tumors

NCT06541262

Conditions
Ewing Sarcoma, Liposarcoma, Myosarcoma, +19 more
Locations
  • University of Alabama/Children's of Alabama Birmingham, Alabama, United States
  • Phoenix Children's Hospital Phoenix, Arizona, United States
  • UCSF Benioff Children's Hospital Oakland Oakland, California, United States
  • Rady Children's Hospital San Diego, California, United States
View all 23 locations
View Trial Details
Recruiting

A Study Comparing Higher Dose Chemotherapy Over a Shorter Amount of Time to Lower Dose Chemotherapy Plus Maintenance Over a Longer Amount of Time in Patients With Newly Diagnosed Intermediate-Risk Rhabdomyosarcoma (IR RMS)

NCT07466316

Conditions
Myosarcoma, Neoplasms, Neoplasms by Histologic Type, +4 more
Locations
  • Mattel Children's Hospital UCLA Los Angeles, California, United States
  • Valley Children's Hospital Madera, California, United States
  • Kaiser Permanente-Oakland Oakland, California, United States
  • Children's Hospital of Orange County Orange, California, United States
View all 87 locations
View Trial Details
Recruiting

Chemotherapy for the Treatment of Patients With Newly Diagnosed Very Low-Risk and Low Risk Fusion Negative Rhabdomyosarcoma

NCT05304585

Conditions
Embryonal Rhabdomyosarcoma, Fusion-Negative Alveolar Rhabdomyosarcoma, Myosarcoma, +8 more
Locations
  • Children's Hospital of Alabama Birmingham, Alabama, United States
  • USA Health Strada Patient Care Center Mobile, Alabama, United States
  • Phoenix Childrens Hospital Phoenix, Arizona, United States
  • Arkansas Children's Hospital Little Rock, Arkansas, United States
View all 181 locations
View Trial Details
Recruiting

Phase I Trial to Determine the Dose and Evaluate the PK and Safety of Lutetium Lu 177 Edotreotide Therapy in Pediatric Participants With SSTR-positive Tumors

NCT06441331

Conditions
CNS Tumors, Central Nervous System Neoplasms, GIST, +29 more
Locations
  • The Children's Hospital of Philadelphia (CHOP) Philadelphia, Pennsylvania, United States
  • University of Texas - MD Anderson Cancer Center Houston, Texas, United States
  • Gustave Roussy Cancer Campus Villejuif, France
  • Hospital Universitario Vall d'Hebron - Oncología Médica Barcelona, Spain
View Trial Details
Recruiting

PEEL-224, Vincristine and Temozolomide in Pediatric Solid Tumors

NCT06721689

Conditions
Disease Attributes, Myosarcoma, Neoplasms, +22 more
Locations
  • Cedars-Sinai Medical Center Los Angeles, California, United States
  • University of California, San Francisco San Francisco, California, United States
  • Boston Children's Hospital Boston, Massachusetts, United States
  • Dana-Farber Cancer Institute Boston, Massachusetts, United States
View Trial Details

Related conditions